FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

258684004: milligram (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
384907012 mg en Synonym Active Entire term case sensitive SNOMED CT core module
384908019 milligram en Synonym Active Entire term case sensitive SNOMED CT core module
2609697015 milligram (qualifier value) en Fully specified name Active Entire term case sensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
milligram Is a International System of Units unit of mass true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely procaine 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely menthol 30 microgram/1 milligram and methyl salicylate 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has concentration strength denominator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely menthol 30 microgram/1 milligram and methyl salicylate 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has concentration strength denominator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely botulism immunoglobulin 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely aclarubicin 20 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 2
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely albiglutide 50 milligram/1 pen powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely camphor 12 microgram/1 milligram and menthol 57 microgram/1 milligram and methyl salicylate 63 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has concentration strength denominator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely camphor 12 microgram/1 milligram and menthol 57 microgram/1 milligram and methyl salicylate 63 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has concentration strength denominator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely camphor 12 microgram/1 milligram and menthol 57 microgram/1 milligram and methyl salicylate 63 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has concentration strength denominator unit True milligram Inferred relationship Existential restriction modifier 3
Product containing precisely trastuzumab 440 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 2
Product containing precisely doxycycline anhydrous (as doxycycline) 75 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely Varicella-zoster virus antibody 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely hydrocortisone 1.67 milligram/1 milliliter conventional release rectal suspension (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely doxycycline anhydrous (as doxycycline) 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely dyclonine hydrochloride 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely drotrecogin alfa 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 3
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely levofloxacin anhydrous (as levofloxacin) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 3
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely human alpha1 proteinase inhibitor 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 2
Product containing precisely warfarin sodium 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cefixime anhydrous (as cefixime) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release oropharyngeal solution (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely somatrem 10 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carmustine 7.7 milligram/1 each prolonged-release intralesional implant (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely lidocaine 25 milligram/1 milliliter and prilocaine 25 milligram/1 milliliter conventional release dental gel (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely lidocaine 25 milligram/1 milliliter and prilocaine 25 milligram/1 milliliter conventional release dental gel (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 2
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cromoglicate sodium 20 milligram/1 actuation conventional release powder for inhalation (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely dinoprostone 10 milligram/1 each prolonged-release vaginal pessary (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 60 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely sulfasalazine 30 milligram/1 milliliter conventional release rectal suspension (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 775 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cilastatin (as cilastatin sodium) 250 milligram and imipenem anhydrous (as imipenem) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cilastatin (as cilastatin sodium) 250 milligram and imipenem anhydrous (as imipenem) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely hexachlorophene 30 milligram/1 milliliter conventional release cutaneous emulsion (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely mitomycin 40 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely mitomycin 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely epinephrine 1 microgram/1 milligram and lidocaine hydrochloride 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has concentration strength denominator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely epinephrine 1 microgram/1 milligram and lidocaine hydrochloride 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has concentration strength denominator unit True milligram Inferred relationship Existential restriction modifier 2
Product containing precisely acetic acid 2.5 milligram/1 milliliter conventional release solution for irrigation (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 2
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely lidocaine 50 microgram/1 milligram conventional release cutaneous patch (clinical drug) Has concentration strength denominator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram/1 each conventional release chewable tablet (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely ceftizoxime (as ceftizoxime sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cefaclor anhydrous (as cefaclor) 75 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator unit False milligram Inferred relationship Existential restriction modifier 2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator unit False milligram Inferred relationship Existential restriction modifier 1
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release oromucosal spray (clinical drug) Has concentration strength numerator unit True milligram Inferred relationship Existential restriction modifier 1

Start Previous Page 72 of 120 Next End

This concept is not in any reference sets

Back to Start